Because of the strong protective effect associated with the RNF186 PTV, studies of RNF186 inhibition and the specific action of this variant protein should be useful in understanding the mechanism by which protection to UC disease occurs and whether this reveals a promising therapeutic opportunity similar to that which has been realized from the example of PCSK9 and cardiovascular disease. Here, RNF186 is linked to cardiovascular disorder.